Morgan Stanley’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-464,630
| Closed | -$31.6M | – | 8178 |
|
2022
Q3 | $31.6M | Sell |
464,630
-391,669
| -46% | -$26.7M | ﹤0.01% | 1712 |
|
2022
Q2 | $27.4M | Buy |
856,299
+287,760
| +51% | +$9.19M | ﹤0.01% | 1942 |
|
2022
Q1 | $19.7M | Buy |
568,539
+367,681
| +183% | +$12.7M | ﹤0.01% | 2130 |
|
2021
Q4 | $5.88M | Sell |
200,858
-110,385
| -35% | -$3.23M | ﹤0.01% | 3548 |
|
2021
Q3 | $7.93M | Sell |
311,243
-238,739
| -43% | -$6.08M | ﹤0.01% | 3176 |
|
2021
Q2 | $19.3M | Buy |
549,982
+374,402
| +213% | +$13.1M | ﹤0.01% | 2192 |
|
2021
Q1 | $7.16M | Sell |
175,580
-97,327
| -36% | -$3.97M | ﹤0.01% | 3028 |
|
2020
Q4 | $11.8M | Buy |
272,907
+163,515
| +149% | +$7.08M | ﹤0.01% | 2329 |
|
2020
Q3 | $6.03M | Buy |
109,392
+25,373
| +30% | +$1.4M | ﹤0.01% | 2532 |
|
2020
Q2 | $5.3M | Sell |
84,019
-317,832
| -79% | -$20.1M | ﹤0.01% | 2599 |
|
2020
Q1 | $20.5M | Buy |
401,851
+149,473
| +59% | +$7.64M | 0.01% | 1256 |
|
2019
Q4 | $20.1M | Buy |
252,378
+131,950
| +110% | +$10.5M | ﹤0.01% | 1657 |
|
2019
Q3 | $5.84M | Sell |
120,428
-35,644
| -23% | -$1.73M | ﹤0.01% | 2694 |
|
2019
Q2 | $8.21M | Sell |
156,072
-5,732
| -4% | -$302K | ﹤0.01% | 2368 |
|
2019
Q1 | $8.57M | Sell |
161,804
-89,077
| -36% | -$4.72M | ﹤0.01% | 2180 |
|
2018
Q4 | $10.3M | Sell |
250,881
-33,501
| -12% | -$1.38M | ﹤0.01% | 2097 |
|
2018
Q3 | $10.8M | Buy |
284,382
+35,878
| +14% | +$1.36M | ﹤0.01% | 2326 |
|
2018
Q2 | $11.2M | Sell |
248,504
-126,743
| -34% | -$5.73M | ﹤0.01% | 2240 |
|
2018
Q1 | $18.1M | Buy |
375,247
+61,336
| +20% | +$2.96M | 0.01% | 1759 |
|
2017
Q4 | $12.4M | Sell |
313,911
-113,577
| -27% | -$4.47M | ﹤0.01% | 2184 |
|
2017
Q3 | $13.3M | Sell |
427,488
-80
| -0% | -$2.48K | ﹤0.01% | 1999 |
|
2017
Q2 | $11.7M | Buy |
427,568
+92,696
| +28% | +$2.54M | ﹤0.01% | 2028 |
|
2017
Q1 | $12.3M | Buy |
334,872
+195,323
| +140% | +$7.2M | ﹤0.01% | 1996 |
|
2016
Q4 | $2.02M | Buy |
139,549
+112,159
| +409% | +$1.62M | ﹤0.01% | 3923 |
|
2016
Q3 | $631K | Sell |
27,390
-45,482
| -62% | -$1.05M | ﹤0.01% | 4378 |
|
2016
Q2 | $1.21M | Buy |
72,872
+35,593
| +95% | +$591K | ﹤0.01% | 3831 |
|
2016
Q1 | $591K | Buy |
37,279
+34,318
| +1,159% | +$544K | ﹤0.01% | 4317 |
|
2015
Q4 | $96K | Sell |
2,961
-83,096
| -97% | -$2.69M | ﹤0.01% | 5430 |
|
2015
Q3 | $3.63M | Buy |
+86,057
| New | +$3.63M | ﹤0.01% | 2936 |
|